celecoxib has been researched along with Fallopian Tube Neoplasms in 2 studies
Fallopian Tube Neoplasms: Benign or malignant neoplasms of the FALLOPIAN TUBES. They are uncommon. If they develop, they may be located in the wall or within the lumen as a growth attached to the wall by a stalk.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Celecoxib was to be continued after DC termination up to 3 years." | 6.77 | A randomized phase II study investigating the addition of the specific COX-2 inhibitor celecoxib to docetaxel plus carboplatin as first-line chemotherapy for stage IC to IV epithelial ovarian cancer, Fallopian tube or primary peritoneal carcinomas: the Do ( de Graaf, H; de Munck, L; Erdkamp, FLG; Hoekman, K; Hollema, H; Lalisang, RI; Polee, M; Reyners, AKL; Schaapveld, M; Smit, WM; van Vugt, MATM; Willemse, PHB; Wymenga, ANM, 2012) |
| "Celecoxib was to be continued after DC termination up to 3 years." | 2.77 | A randomized phase II study investigating the addition of the specific COX-2 inhibitor celecoxib to docetaxel plus carboplatin as first-line chemotherapy for stage IC to IV epithelial ovarian cancer, Fallopian tube or primary peritoneal carcinomas: the Do ( de Graaf, H; de Munck, L; Erdkamp, FLG; Hoekman, K; Hollema, H; Lalisang, RI; Polee, M; Reyners, AKL; Schaapveld, M; Smit, WM; van Vugt, MATM; Willemse, PHB; Wymenga, ANM, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, R | 1 |
| Cristea, M | 1 |
| Frankel, P | 1 |
| Ruel, C | 1 |
| Chen, C | 1 |
| Wang, Y | 1 |
| Morgan, R | 1 |
| Leong, L | 1 |
| Chow, W | 1 |
| Koczywas, M | 1 |
| Koehler, S | 1 |
| Lim, D | 1 |
| Luu, T | 1 |
| Martel, C | 1 |
| McNamara, M | 1 |
| Somlo, G | 1 |
| Twardowski, P | 1 |
| Yen, Y | 1 |
| Idorenyi, A | 1 |
| Raechelle, T | 1 |
| Carroll, M | 1 |
| Chung, V | 1 |
| Reyners, AKL | 1 |
| de Munck, L | 1 |
| Erdkamp, FLG | 1 |
| Smit, WM | 1 |
| Hoekman, K | 1 |
| Lalisang, RI | 1 |
| de Graaf, H | 1 |
| Wymenga, ANM | 1 |
| Polee, M | 1 |
| Hollema, H | 1 |
| van Vugt, MATM | 1 |
| Schaapveld, M | 1 |
| Willemse, PHB | 1 |
2 trials available for celecoxib and Fallopian Tube Neoplasms
| Article | Year |
|---|---|
Randomized trial of oral cyclophosphamide versus oral cyclophosphamide with celecoxib for recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antineoplastic Agents | 2019 |
A randomized phase II study investigating the addition of the specific COX-2 inhibitor celecoxib to docetaxel plus carboplatin as first-line chemotherapy for stage IC to IV epithelial ovarian cancer, Fallopian tube or primary peritoneal carcinomas: the Do
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcino | 2012 |